Sofosbuvir
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3763 publications
Hepatitis E virus infections in immunocompromised patients.
Journal: Clinical microbiology reviews
Published: October 26, 2026
Direct Ketone Cyclopropanation Enabled by Tebbe's Reagent.
Journal: Tetrahedron letters
Published: October 15, 2026
Sofosbuvir/Daclatasvir versus Grazoprevir/Elbasvir in Patients with Chronic Hepatitis C on Haemodialysis: A Multicentre, Single-Blind, Randomised Controlled Trial.
Journal: Acta medica Indonesiana
Published: October 08, 2026
MDL-001: An Oral, Direct-Acting Broad-Spectrum Antiviral for Influenza-like Illness (ILI) and Chronic Hepatitis In Vivo.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 18, 2026
Development, characterisation and preclinical evaluation of curcumin-loaded solid lipid nanoparticles for enhanced antiviral delivery against Zika virus infection.
Journal: Journal of drug targeting
Published: July 14, 2026
Novel Mechanisms of SARS-CoV-2 Drug Resistance and Rational Design of Anti-Resistant Antivirals.
Journal: Molecules (Basel, Switzerland)
Published: July 14, 2026
Direct-Acting Antivirals in Patients with Comorbidities for the Simplified Management of HCV Infection: An Expert Review with a Focus on Sofosbuvir-Velpatasvir.
Journal: Viruses
Published: July 07, 2026
Targeting the allosteric mechanism of methicillin-resistant Staphylococcus aureus pyruvate kinase: From inhibitor discovery to network reorganization.
Journal: International journal of biological macromolecules
Published: June 24, 2026
Chiral-Modified Nucleoside Analogues: From Bioactivity to Therapeutic Applications.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 23, 2026
Drug repurposing for psoriasis: virtual screening, molecular dynamics, and ADMET profiling for the identification of potential DHFR inhibitors.
Journal: In silico pharmacology
Published: June 15, 2026
Outcomes After 4-Week Course of Sofosbuvir/Velpatasvir Therapy in Hepatitis C Seronegative Recipients of Kidneys From Hepatitis C Viremic Deceased Donors.
Journal: Clinical transplantation
Published: June 05, 2026
Rare and Novel Hepatitis C Virus Genotype Subtypes and Response to Sofosbuvir/Velpatasvir in A5360 (MINMON) Clinical Trial.
Journal: Journal of viral hepatitis
Published: June 05, 2026
Last Updated: 11/08/2026